INVESTOR AB — 13F Holdings & Portfolio
CIK 889232 · latest 13F-HR filed 2026-08-14
INVESTOR AB manages $14.40B in 13F-reported U.S. long-equity assets across 7 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are AZN (67.92%), NDAQ (31.98%), MDWD (0.09%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 1 new position, exited 4, added to 1, and trimmed 3.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
SE-103 32
STOCKHOLM 00000
$14.40B
Long-equity book
7
Distinct positions
2026-06-30
Filed 2026-08-14
+1 / −4 / ↑1 / ↓3
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Trims
- NASDAQ INC-$326.6M -6.6%
- MEDIWOUND LTD-$1.2M -8.8%
- VERIZON COMMUNICATIONS INC-$88.8K -15.7%
Exited Positions
- COHERENT CORP$714.6K
- KYIVSTAR GROUP LTD$601.1K
- CORSAIR GAMING INC$553.4K
- WHIRLPOOL CORP$253.4K
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | ASTRAZENECA PLC | AZN | G0593M107 | $9.78B | 67.92% | 51,587,810 | SH |
| 2 | NASDAQ INC | NDAQ | 631103108 | $4.61B | 31.98% | 58,439,208 | SH |
| 3 | MEDIWOUND LTD | MDWD | M68830112 | $12.8M | 0.09% | 872,093 | SH |
| 4 | CELLEBRITE DI LTD | CLBT | M2197Q107 | $1.1M | 0.01% | 75,000 | SH |
| 5 | MICRON TECHNOLOGY INC | MU | 595112103 | $542.5K | 0.00% | 470 | SH |
| 6 | VERIZON COMMUNICATIONS INC | VZ | 92343V104 | $478.4K | 0.00% | 11,300 | SH |
| 7 | BIOMARIN PHARMACEUTICAL INC | BMRN | 09061G101 | $211.7K | 0.00% | 3,700 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $14.40B | 7 | 0001493152-26-038312 |
| 2026-03-31 | 2026-05-15 | $15.12B | 10 | 0001493152-26-023718 |
| 2025-12-31 | 2026-02-17 | $5.67B | 12 | 0001493152-26-007094 |
| 2025-09-30 | 2025-11-14 | $5.17B | 12 | 0001493152-25-023420 |